Clinical Trials Logo
  1. Home
  2. Diabetic Neuropathic Pain
  3. NCT06336486

the Effectiveness of Intermittent Pneumatic Compression on Neuropathic Pain in Patients With Diabetic Polyneuropathy

Diabetic Neuropathic Pain Clinical Trial

Official title:
Comparison of the Effectiveness of Pregabalin Therapy on Neuropathic Pain in Patients With Diabetic Polyneuropathy and the Treatments Applied in Patients Receiving Pregabalin and Intermittent Pneumatic Compression Therapy

Clinical Trial Summary

In this study,the effectiveness of intermittent pneumatic compression therapy on neuropathic pain and quality of life in patients with neuropathic pain due to type 2 diabetes was investigated

Clinical Trial Description

The investigators conducted our research from 50 patients with type 2 diabetes of 5-20 years, who received pregabalin treatment with diabetic neuropathy with consent form between 40-75 years.The investigators divided the patients into two equal groups , some of the patients were given an intermittent pneumatic compression program at a pressure of 35 mmhg for 30 min to the lower extremity for 10 days of extreme alternation in our clinic and pregabalin treatment was continued,only pregabalin treatment of the other group was continued. VAS, PQAS, LANSS, SF-36 were evaluated.The evaluation was done before the treatment, at the end of the intermittent pneumatic compression treatment(approximately 2 weeks after the start of the treatment) and 3 months later. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT06336486
Study type Interventional
Source Balikesir University
Contact
Status Completed
Phase N/A
Start date December 4, 2018
Completion date February 1, 2020
View Details
See also
  Status Clinical Trial Phase
Completed NCT02783469 - Genetics of Diabetes Audit and Research in Tayside Scotland (DOLORisk Dundee)
Completed NCT05563454 - A Study to Learn How Safe the Study Treatment BAY2395840 is, How it Affects the Body and How it Moves Into, Through, and Out of the Body if Given in Single and in Repetitive Doses to Japanese Healthy Male Participants Phase 1
Not yet recruiting NCT04137328 - Clinical Study on the Improvement of Diabetic Neuropathic Pain by Liraglutide N/A
Completed NCT00548925 - A Safety and Efficacy Study in Subjects With Diabetic Neuropathic Pain Phase 2
Completed NCT00452777 - Efficacy and Tolerability of Novel A2A Agonist in Treatment of Diabetic Neuropathic Pain Phase 2
Withdrawn NCT05406219 - A Study to Learn How the Study Treatment BAY2395840 Moves Into, Through and Out of the Body, How Safe it is, and How it Affects the Body in Participants With Moderate Reduced Kidney Function and in Healthy Male and Female Participants With Normal Kidney Function Phase 1
Active, not recruiting NCT05351801 - Proof of Concept Trial of Cannabis Derivatives in Neuropathic Pain Phase 2
Completed NCT04454424 - Study on the Safety of BAY1817080, How it is Tolerated and the Way the Body Absorbs, Distributes and Gets Rid of the Study Drug in Participants With Impaired Liver Function or Normal Liver Function Phase 1
Recruiting NCT05986292 - A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices (ISAs) in Participants With Chronic Pain Phase 2
Terminated NCT00619983 - Three Way Interaction Between Gabapentin, Duloxetine, and Donepezil in Patients With Diabetic Neuropathy Phase 4
Completed NCT04265781 - Study on the Safety of Drug BAY1817080 at Different Doses and the Way the Body Absorbs and Eliminates the Drug in Japanese Healthy Adult Male Participants Phase 1
Completed NCT04487431 - A Trial to Learn How a New Liquid Form of BAY1817080 is Tolerated and Taken up by the Body of Healthy Male Participants (Part A). By Labeling BAY1817080 With a Radioactive Substance (Carbon 14) Researchers Want to Learn How the Study Drug is Processed and Excreted by the Body After Dosing (Part B) Phase 1
Completed NCT04471337 - Study on the Safety of BAY1817080 How it is Tolerated and the Way the Body Absorbs, Distributes and Gets Rid of the Study Drug Given to Participants With Moderate Renal Impairment and End Stage Renal Disease Requiring Dialysis Compared With Matched Participants With Normal Renal Function Phase 1
Terminated NCT01579279 - A Study Comparing the Efficacy and Safety of ABT-652 to Placebo in Subjects With Diabetic Neuropathic Pain Phase 2
Completed NCT01589432 - A Randomized, Double-blind, Placebo- and Active-controlled Study of the Electric Current Effects of ABT-639 on the Spontaneous Activity of Pain Sensory Receptors in Patients With Diabetic Peripheral Neuropathy Phase 2
Completed NCT01345045 - A Multicenter Study Comparing the Analgesic Effects and Safety of ABT-639 Compared to Placebo in Subjects With Diabetic Neuropathic Pain Phase 2